The Filing Desk

Janux Therapeutics vs Prothena

Janux Therapeutics JANX · Prothena PRTA · Biotechnology

Janux Therapeutics reported revenue of $10 million in fiscal 2025, about the same as Prothena's $10 million in fiscal 2025. Janux Therapeutics' revenue fell 5.5% in its latest year, and Prothena's fell 92.8%. Janux Therapeutics had an operating margin of -1576.7%, against -2216.4% at Prothena.

Side by side

Janux TherapeuticsProthena
Latest fiscal yearFY2025, Dec 31, 2025FY2025, Dec 31, 2025
Revenue$10M$10M
Revenue growth−5.5%−92.8%
Revenue growth a year, last 5 years—60.9%
Gross margin——
Operating margin−1,576.7%−2,216.4%
Net margin−1,136.2%−2,520.6%
Free cash flow−$83M—
Free cash flow margin−832.8%—
Return on capital——
Net debt to EBITDA——
Dividends and buybacks$0M$0M
Change in diluted share count15.3%0.1%
Last close$10.29$8.40
P/E at the last close——
Insider trades, last 12 monthssold $457,063bought $7.7 million, sold $135,926
Piotroski F-score——
Amounts in each company's own currency, US$ unless marked (a foreign company may report in another), each company's latest fiscal year from its 10-K, or 20-F or 40-F for a foreign company. Growth rates compare with the year before; the five-year rate is the average a year. Free cash flow is cash from operations minus capital spending; return on capital is after-tax operating income over the money invested in the business; P/E is the last close over the latest earnings per share. Banks are measured differently (return on equity, efficiency ratio), so some rows apply to one company only.

Ten years

Revenue
US$ billions, fiscal years
Janux TherapeuticsProthena
Operating margin
Percent of revenue
Janux TherapeuticsProthena
Free cash flow
US$ billions. Cash from operations minus capital expenditure.
Janux TherapeuticsProthena

Start a new comparison

Source: the companies' Form 10-K filings, from SEC EDGAR, and the last close. For information only, not investment advice: the figures describe results, not which company is the better investment. The Filing Desk is not affiliated with either company. Full figures on the Janux Therapeutics and Prothena pages.